The diagnostic performance of lysine(K)-specific demethylase 6B ( KDM6B ) in non-small cell lung cancer
Source abstract
Abstract
Objectives Accumulating evidence show that histone demethylases play important roles in various types of cancers, including non-small cell lung cancer (NSCLC). In the current study, we evaluated the diagnostic value of lysine(K)-specific demethylase 6B (KDM6B) in NSCLC.Methods Serum KDM6B expression levels of 115 NSCLC patients and 88 healthy volunteers were detected by reverse transcription quantitative real-time polymerase chain reaction (qRT-PCR). The relationship between KDM6B and clinical characteristics was assessed by chi-square test. Receiver operating characteristic (ROC) analysis was applied to evaluate diagnostic efficacy.Results Serum KDM6B was significantly lower in NSCLC patients than that in healthy controls (p < .001). Moreover, low KDM6B expression was significantly associated with the high clinical stage (p = .028) and positive lymph node metastasis (p = .031). Besides, we found that the expression of KDM6B mRNA was also significantly different among healthy controls, NSCLC early stage and later stage patients (p < .05). ROC curve indicated that KDM6B could serve as a diagnostic marker for NSCLC with the cut-off value of 0.955. The AUC was 0.897 with a sensitivity of 79.5% and specificity of 84.3%.Conclusion Down-regulation of KDM6B is significantly associated with aggressive progression of NSCLC and KDM6B may be a tool of early detection of NSCLC.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Epigenetics and DNA Methylation · Cancer-related gene regulation · Cancer-related molecular mechanisms research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Respiratory Department, Ningbo Medical Center Lihuili Hospital
Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine
Department of Oncology, Renji Hospital, Affiliated to Shanghai Jiaotong University School of Medicine
Funding
The Science and Technology Scheme of Ningbo
References (31)
Show source-provided references
1. 10.3322/caac.2013810.3322/caac.20138 ↗
2. 10.1159/00035660510.1159/000356605 ↗
3. 10.1007/s13277-014-1763-x10.1007/s13277-014-1763-x ↗
4. 10.1155/2016/382312110.1155/2016/3823121 ↗
5. 10.3389/fonc.2014.0029210.3389/fonc.2014.00292 ↗
6. 10.1016/S0140-6736(13)61502-010.1016/S0140-6736(13)61502-0 ↗
7. 10.1021/cr100420s10.1021/cr100420s ↗
8. Cabrera-Alarcon JL, Carrillo-Vico A, Santotoribio JD, et al. CYFRA 21-1 as a tool for distant metastasis detection in lung cancer. Clin Lab. 2011;57:1011–1014.
9. 10.1016/S0959-8049(11)70171-X10.1016/S0959-8049(11)70171-X ↗
10. 10.1586/14789450.6.1.2710.1586/14789450.6.1.27 ↗
11. 10.1371/journal.pone.007807010.1371/journal.pone.0078070 ↗
12. 10.1016/j.molonc.2012.07.00410.1016/j.molonc.2012.07.004 ↗
13. 10.1016/j.molcel.2007.03.00110.1016/j.molcel.2007.03.001 ↗
14. 10.1158/0008-5472.CAN-13-189610.1158/0008-5472.CAN-13-1896 ↗
15. 10.1158/0008-5472.CAN-12-316510.1158/0008-5472.CAN-12-3165 ↗
16. 10.1080/15592294.2015.110357810.1080/15592294.2015.1103578 ↗
17. 10.1245/s10434-015-4879-310.1245/s10434-015-4879-3 ↗
18. 10.1371/journal.pone.005140710.1371/journal.pone.0051407 ↗
19. 10.1159/00043034510.1159/000430345 ↗
20. 10.18632/oncotarget.763810.18632/oncotarget.7638 ↗
21. 10.1007/978-1-4419-9967-2_410.1007/978-1-4419-9967-2_4 ↗
22. 10.1038/nrg194510.1038/nrg1945 ↗
23. 10.1016/j.bbcan.2010.10.00210.1016/j.bbcan.2010.10.002 ↗
24. 10.1371/journal.pone.000468710.1371/journal.pone.0004687 ↗
25. 10.4161/epi.4.2.803810.4161/epi.4.2.8038 ↗
26. Tian C, Deng H, Tang X, et al. Effect of Jumonji domain-containing protein-3 on the proliferation and migration of lung cancer cell line. Sheng wu yi Xue Gong Cheng Xue za Zhi = J Biomed Eng = Shengwu Yixue Gongchengxue Zazhi. 2012;29:514–518.
27. 10.3233/CBM-2009-012810.3233/CBM-2009-0128 ↗
28. 10.1093/carcin/bgu13610.1093/carcin/bgu136 ↗
29. 10.1093/hmg/ddr39910.1093/hmg/ddr399 ↗
30. 10.1038/onc.2010.57910.1038/onc.2010.579 ↗
31. Li Q, Hou L, Ding G, et al. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Int J Clin Exp Pathol. 2015;8:6334–6344.